|
1
|
Vogel A, Meyer T, Sapisochin G, Salem R
and Saborowski A: Hepatocellular carcinoma. Lancet. 400:1345–1362.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chidambaranathan-Reghupaty S, Fisher PB
and Sarkar D: Hepatocellular carcinoma (HCC): Epidemiology,
etiology and molecular classification. Adv Cancer Res. 149:1–61.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
D'Souza S, Lau KC, Coffin CS and Patel TR:
Molecular mechanisms of viral hepatitis induced hepatocellular
carcinoma. World J Gastroenterol. 26:5759–5783. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang C, Huang X, Liu Z, Qin W and Wang C:
Metabolism-associated molecular classification of hepatocellular
carcinoma. Mol Oncol. 14:896–913. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sasaki-Tanaka R, Ray R, Moriyama M, Ray RB
and Kanda T: Molecular changes in relation to alcohol consumption
and hepatocellular carcinoma. Int J Mol Sci. 23:96792022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Torimura T and Iwamoto H: Treatment and
the prognosis of hepatocellular carcinoma in Asia. Liver Int.
42:2042–2054. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moll R, Divo M and Langbein L: The human
keratins: Biology and pathology. Histochem Cell Biol. 129:705–733.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen W and Miao C: KRT15 promotes
colorectal cancer cell migration and invasion through
β-catenin/MMP-7 signaling pathway. Med Oncol. 39:682022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kohler KT, Goldhammer N, Demharter S,
Pfisterer U, Khodosevich K, Rønnov-Jessen L, Petersen OW, Villadsen
R and Kim J: Ductal keratin 15+ luminal progenitors in
normal breast exhibit a basal-like breast cancer transcriptomic
signature. NPJ Breast Cancer. 8:812022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giroux V, Stephan J, Chatterji P, Rhoades
B, Wileyto EP, Klein-Szanto AJ, Lengner CJ, Hamilton KE and Rustgi
AK: Mouse intestinal Krt15+ crypt cells are radio-resistant and
tumor initiating. Stem Cell Reports. 10:1947–1958. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin JB, Feng Z, Qiu ML, Luo RG, Li X and
Liu B: KRT 15 as a prognostic biomarker is highly expressed in
esophageal carcinoma. Future Oncol. 16:1903–1909. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Liang Y, Ma MH, Wu KZ and Dai DQ:
KRT15, INHBA, MATN3, and AGT are aberrantly methylated and
differentially expressed in gastric cancer and associated with
prognosis. Pathol Res Pract. 215:893–899. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rao X, Wang J, Song HM, Deng B and Li JG:
KRT15 overexpression predicts poor prognosis in colorectal cancer.
Neoplasma. 67:410–414. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Liu Y, Liu B, Wang J, Wei S, Qi Z,
Wang S, Fu W and Chen YG: A growth factor-free culture system
underscores the coordination between Wnt and BMP signaling in
Lgr5+ intestinal stem cell maintenance. Cell Discov.
4:492018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lei KF, Liu TK and Tsang NM: Towards a
high throughput impedimetric screening of chemosensitivity of
cancer cells suspended in hydrogel and cultured in a paper
substrate. Biosens Bioelectron. 100:355–360. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian S, Lou L, Tian M, Lu G, Tian J and
Chen X: MAPK4 deletion enhances radiation effects and triggers
synergistic lethality with simultaneous PARP1 inhibition in
cervical cancer. J Exp Clin Cancer Res. 39:1432020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang H, Li A, Li A, Zhao F and Zhang T:
Upregulated keratin 15 links to the occurrence of lymphovascular
invasion, stromal cervical invasion as well as unfavorable survival
profile in endometrial cancer patients. Medicine (Baltimore).
101:e296862022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong P, Shu R, Wu H, Liu Z, Shen X and Hu
Y: Low KRT15 expression is associated with poor prognosis in
patients with breast invasive carcinoma. Exp Ther Med. 21:3052021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zekri AN, El-Sisi ER, Abdallah ZF, Ismail
A and Barakat Barakat A: Gene expression profiling of circulating
CD133+ cells of hepatocellular carcinoma patients
associated with HCV infection. J Egypt Natl Canc Inst. 29:19–24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abbas O, Richards JE, Yaar R and
Mahalingam M: Stem cell markers (cytokeratin 15, cytokeratin 19 and
p63) in in situ and invasive cutaneous epithelial lesions. Mod
Pathol. 24:90–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alam Khan S and Jawaid Akhtar M:
Structural modification and strategies for the enhanced doxorubicin
drug delivery. Bioorg Chem. 120:1055992022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang Y, Jeong SW, Young Jang J and Jae
Kim Y: Recent updates of transarterial chemoembolilzation in
hepatocellular carcinoma. Int J Mol Sci. 21:81652020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manjunatha N, Ganduri V, Rajasekaran K,
Duraiyarasan S and Adefuye M: Transarterial chemoembolization and
unresectable hepatocellular carcinoma: A narrative review. Cureus.
14:e284392022.PubMed/NCBI
|
|
26
|
Al-Malky HS, Al Harthi SE and Osman AM:
Major obstacles to doxorubicin therapy: Cardiotoxicity and drug
resistance. J Oncol Pharm Pract. 26:434–444. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buschauer S, Koch A, Wiggermann P, Müller
M and Hellerbrand C: Hepatocellular carcinoma cells surviving
doxorubicin treatment exhibit increased migratory potential and
resistance to doxorubicin re-treatment in vitro. Oncol Lett.
15:4635–4640. 2018.PubMed/NCBI
|
|
28
|
Marin JJG, Macias RIR, Monte MJ, Romero
MR, Asensio M, Sanchez-Martin A, Cives-Losada C, Temprano AG,
Espinosa-Escudero R, Reviejo M, et al: Molecular bases of drug
resistance in hepatocellular carcinoma. Cancers (Basel).
12:16632020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ceballos MP, Rigalli JP, Cere LI, Semeniuk
M, Catania VA and Ruiz ML: ABC transporters: Regulation and
association with multidrug resistance in hepatocellular carcinoma
and colorectal carcinoma. Curr Med Chem. 26:1224–1250. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagaraju GP, Farran B, Luong T and
El-Rayes BF: Understanding the molecular mechanisms that regulate
pancreatic cancer stem cell formation, stemness and
chemoresistance: A brief overview. Semin Cancer Biol. 88:67–80.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He S and Tang S: WNT/β-catenin signaling
in the development of liver cancers. Biomed Pharmacother.
132:1108512020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schaefer KN, Bonello TT, Zhang S, Williams
CE, Roberts DM, McKay DJ and Peifer M: Supramolecular assembly of
the beta-catenin destruction complex and the effect of Wnt
signaling on its localization, molecular size, and activity in
vivo. PLoS Genet. 14:e10073392018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pfister AS and Kühl M: Of Wnts and
ribosomes. Prog Mol Biol Transl Sci. 153:131–155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma Y, Ma M, Sun J, Li W, Li Y, Guo X and
Zhang H: CHIR-99021 regulates mitochondrial remodelling via
β-catenin signalling and miRNA expression during endodermal
differentiation. J Cell Sci. 132:jcs2299482019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng Z, Mabrouk I, Msuthwana P, Zhou Y,
Song Y, Gong H, Li S, Min C, Ju A, Duan A, et al: In ovo injection
of CHIR-99021 promotes feather follicles development via activating
Wnt/β-catenin signaling pathway during chick embryonic period.
Poult Sci. 101:1018252022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Delepine C, Pham VA, Tsang HWS and Sur M:
GSK3ß inhibitor CHIR 99021 modulates cerebral organoid development
through dose-dependent regulation of apoptosis, proliferation,
differentiation and migration. PLoS One. 16:e02511732021.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF
and Chen X: β-Catenin signaling in hepatocellular carcinoma. J Clin
Invest. 132:e1545152022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leung RWH and Lee TKW: Wnt/β-Catenin
signaling as a driver of stemness and metabolic reprogramming in
hepatocellular carcinoma. Cancers (Basel). 14:54682022. View Article : Google Scholar : PubMed/NCBI
|
